Pfizer study tests new drug in people with liver issues
NCT ID NCT07269301
First seen Jan 08, 2026 · Last updated May 13, 2026 · Updated 25 times
Summary
This study looks at how different levels of liver function affect the way the body processes a new medicine called PF-07328948. Researchers will give a single tablet to 26 adults, some with liver problems and some healthy, and monitor them for about 6 days. The goal is to learn if liver impairment changes how the drug works in the body, which helps guide future dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Genesis Clinical Research, LLC
RECRUITINGTampa, Florida, 33603, United States
-
Orange County Research Center
RECRUITINGLake Forest, California, 92630, United States
-
Orlando Clinical Research Center
RECRUITINGOrlando, Florida, 32809, United States
Conditions
Explore the condition pages connected to this study.